Lovell Stephanie
- SEC CIK
- 0001772054
In the past year, 1 open-market sale filing worth $178.5K and no purchases.
Current role at each company
- TMDX TransMedics Group, Inc.Directoras of May 22, 2026
- KRSA Korsana Biosciences, Inc.Directoras of Jun 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $178.5K
- 1 filing
- Net
- −$178.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lovell Stephanie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TMDX TransMedics Group, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 (view filing) | Nov 22-23 | 1 day | Lovell StephanieDirector | SSale | −10.6K | $58.80 | −$620.7K | −100.0%0 after | 3 lots |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Lovell StephanieDirector | SSale | −1.19K | $149.62 | −$178.5K | −29.4%2.87K after |